AI coding agents ported Fields Medalist Terence Tao’s Java 1.0 math visualizations to JavaScript in hours, identified two ...

After creating KB Matrix to connect textured hair stylists with clients across Europe, Netochukwu Onuoha is taking on PR with Inkognito.AI At just 27 years old, Netochukwu Onuoha is already a serial ...

Deputy Prime Minister Gan Kim Yong speaks at the launch of Applied Materials' new campus in Tampines on Jun 10, 2026. (Photo: Economic Development Board) SINGAPORE: Semiconductor equipment maker ...

SINGAPORE - Applied Materials opened the doors of its new plant to produce chip-making machines, doubling its manufacturing footprint in Singapore and creating 1,000 new local jobs over the next few ...

D-Matrix says its chips can run inference workloads 10 times faster and using five times less energy than a standalone graphics processing unit from Nvidia. Like Cerebras, D-Matrix is trying to prove ...

Shrishty is a decade-old journalist covering a variety of beats between politics to pop culture, but movies are her first love, which led her to study Film and TV Development at UCLAx. She lives and ...

Data centers face a conundrum: how to power increasingly dense server racks using equipment that relies on century-old technology. Traditional transformers are bulky and hot, but a new generation of ...

Astrophysicist Neil deGrasse Tyson and Laurence Fishburne unpack The Matrix’s hidden biblical parallels, from Neo as “The One” to Morpheus as a John the Baptist figure. As “The Matrix” reportedly ...

CAMBRIDGE, England & DETROIT--(BUSINESS WIRE)--Cycle Group Holdings Limited (“Cycle”) is delighted to announce it has completed the acquisition of NASDAQ-listed Applied Therapeutics, Inc. (NASDAQ: ...

Applied Digital's nearly $16 billion in contracted backlog for AI data center-related revenue highlights its robust long-term demand visibility. This includes an expanded contract with hyperscaler ...

Cycle Pharmaceuticals is circling up Applied Therapeutics, acquiring the rare disease biotech after an extremely tumultuous year for the latter that began with an FDA rejection at the end of 2024.